India to conduct Russian vaccine's Phase 3 trials?
September 09, 2020
Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology will now submit comprehensive data on the safety and efficacy of the Russian vaccine candidates to the Indian authorities,
Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology will now submit comprehensive data on the safety and efficacy of the Russian vaccine candidates to the Indian authorities,
0 comments